Micronutrient Assessment in Long-Term Home Parenteral Nutrition Patients

Abstract

Assessment of micronutrient status of patients requiring long-term parenteral nutrition (PN) continues to be a challenge for clinicians. The scientific literature primarily consists of small studies and case reports. There are no evidence-based guidelines available. Clinicians rely on clinical assessment according to the patient's disease process, medication regimen, physical examination, and history of nutrient intake to determine existence or risk of micronutrient deficiency and toxicity. This paper will examine current scientific evidence and existing recommendations for the micronutrient assessment and management of patients requiring long-term PN.

Get full access to this article

View all access options for this article.

References

Fuhrman MP, Herrmann VM, Masidonski P, Eby C. Pancytopenia after removal of copper from total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000;24:361– 366.

Howard L, Chu R, Feman S, Mintz H, Ovesen L, Wolf B. Vitamin A deficiency from long-term parenteral nutrition. Ann Intern Med. 1980;93:576– 577.

Abumrad NN, Schneider AJ, Steel D, Rogers LS. Amino acid intolerance during prolonged total parenteral nutrition therapy reversed by molybdate therapy. Am J Clin Nutr. 1981 ;34:2551– 2559.

Ibrahim M, de Escobar GM, Visser TJ, et al. Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003 ;88:F56– F57.

van Rij AM, Thompson D, McKenzie JM, Robinson MF. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr. 1979;32:2076– 2085.

Frankel DA. Supplementation of trace elements in parenteral nutrition: rationale and recommendations. Nutr Res. 1993 ;13:583– 596.

Allen JI, Perri RT, McClain CJ, Kay NE. Alternatives in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med. 1983 ;102:577– 589.

Siepler J, Nishikawa R, Diamantidis T, Okamoto R. Elevated manganese levels in long-term home parenteral nutrition patients are not predicted by dose [abstract]. JPEN J Parenter Enteral Nutr. 2001;25:S7 . Abstract 0024.

Moukarzel AA, Song MK, Buchman AL, et al. Excessive chromium intake in children receiving total parenteral nutrition. Lancet. 1992;339:385– 388.

10.

Faintuch J, Faintuch JJ, Toledo M, Nazario G, Machado MC, Raia AA. Hyperamylasemia associated with zinc overdose during parenteral nutrition. JPEN J Parenter Enteral Nutr. 1978 ;2:640– 645.

11.

Bishop NJ, Morley R, Day JP, Lucas A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med. 1997;336:1557– 1561.

12.

Deaths associated with thiamin-deficient total parenteral nutrition (TPN). MMWR Morb Mortal Wkly Rep. 1989 ;38:43– 46.

13.

Lactic acidosis traced to thiamin deficiency related to nationwide shortage of multivitamins for TPN: United States 1997. MMWR Morb Mortal Wkly Rep. 1997;46:522– 528.

14.

Fuhrman MP. Overview of micronutrients and parenteral nutrition. Support Line. 2002 ;24:5– 12.

15.

Neve J. New approaches to assess selenium status and requirement. Nutr Rev. 2000;58:363– 369.

16.

Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Plasma zinc is an insensitive predictor of zinc status: use of plasma zinc in children with sickle cell disease. Nutr Clin Pract. 2003 ;17:365– 372.

17.

Fuhrman MP, Parker M. Micronutrient assessment. Support Line. 2004;26:17– 24.

18.

Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 ;28:S39– S70. Erratum 2006;30:177.

19.

Bertinet DB, Tinivella M, Balzola FA, et al. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000 ;24:223– 227.

20.

Wardle CA, Forbes A, Roberts NB, Jawhari AV, Shenkin A. Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. JPEN J Parenter Enteral Nutr. 1999 ;23:350– 355.

21.

Hak EB, Storm MC, Helms RA. Chromium and zinc contamination of parenteral nutrient solution components commonly used in infants and children. Am J Health Syst Pharm. 1998 ;55:150– 154.

22.

Mouser JF, Hak E, Helms R, Christensen M, Storm MC. Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition. Am J Health Syst Pharm. 1999 ;56:1950– 1956.

23.

Ireton-Jones C. Outcomes of home nutrition support: fact or fiction? Support Line. 2006 ;28:25– 28.

24.

Pluhator-Murton MM, Fedorak RN, Audette RJ, Marriage BJ, Yatscoff RW, Gramlich LM. Trace element contamination of total parenteral nutrition, 1: contribution of component solutions. JPEN J Parenter Enteral Nutr. 1999;23:222– 227.

25.

DeTommaso D, Fuhrman MP. Aluminum in parenteral nutrition products: clinical considerations. Support Line. 2004 ;26:13,16– 21.

26.

Pluhator-Murton MM, Fedorak RN, Audette RJ, Marriage BJ, Yatscoff RW, Gramlich LM. Trace element contamination of total parenteral nutrition, 2: effect of storage duration and temperature. JPEN J Parenter Enteral Nutr. 1999;23:228– 232.

27.

Kelly DG, Fleming R. Nutritional considerations in inflammatory bowel diseases. Gastroenterol Clin North Am. 1995 ;24:597– 611.

28.

Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anemia, and inflammatory bowel diseases. Gut. 2004 ;53:1190– 1197.

29.

Hamilton C, Steiger E, Seidner DL. Parenteral nutrition. In: Matarese LE, Steiger E, Seidner DL, eds. Intestinal Failure and Rehabilitation: A Clinical Guide. Boca Raton, FL: CRC Press;2005 : 229–248.

30.

Yusuf SW, Rehman Q, Casscells W. Cardiomyopathy in association with selenium deficiency: a case report. JPEN J Parenter Enteral Nutr. 2002;26:63– 66.

31.

Kanekura T, Yotsumoto S, Maeno N, et al. Selenium deficiency: report of a case. Clin Exp Dermatol. 2005 ;30:346– 348.

32.

Ishida T, Himeno K, Torgoe Y, et al. Selenium deficiency in a patient with Crohn's disease receiving long-term total parenteral nutrition. Intern Med. 2003 ;42:154– 157.

33.

Inoko M, Konishi T, Matsusue S, Kobashi Y. Midmural fibrosis of left ventricle due to selenium deficiency. Circulation. 1998 ;98:2638– 2639.

34.

Kawakubo K, Iida M, Matsumoto T, et al. Progressive encephalopathy in a Crohn's disease patient on long-term total parenteral nutrition: possible relationship to selenium deficiency. Postgrad Med J. 1994 ;70:215– 219.

35.

Kelly DA, Coe AW, Shenkin A, Lake BD, Walker-Smith JA. Symptomatic selenium deficiency in a child on home parenteral nutrition. J Pediatr Gastroenterol Nutr. 1988 ;7:783– 786.

36.

Forbes GM, Forbes A. Micronutrient status in patients receiving home parenteral nutrition. Nutrition. 1997 ;13:941– 944.

37.

Okada A, Takagi Y, Nezu R, Sando K, Shenkin A. Trace element metabolism in parenteral and enteral nutrition. Nutrition. 1995 ;11:106– 113.

38.

Angstwurm MWA, Gaertner R. Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9:233– 238.

39.

Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors? Scand J Gastroenterol. 1998 ;33:1057– 1061.

40.

Hatanaka N, Nakaden H, Yamamoto Y, Matsuo S, Fujikawa T, Matsusue S. Selenium kinetics and changes in glutathione peroxidase activities in patients receiving long-term parenteral nutrition and effects of supplementation with selenite. Nutrition. 2000 ;16:22– 26.

41.

Drongowski RA, Coran AG. Analysis of factors contributing to the development of total parenteral nutrition (TPN)-induced cholestasis. JPEN J Parenter Enteral Nutr. 1989 ;13:86– 89.

42.

Kumar N, Gross JB, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004 ;63:33– 39.

43.

Hurwitz M, Garcia MG, Poole RL, Kerner JA. Copper deficiency during parenteral nutrition: a report of four pediatric cases. Nutr Clin Pract. 2004;19:305– 308.

44.

Mehta R, Reilly JJ. Manganese levels in a jaundiced long-term total parenteral nutrition patient: potentiation of haloperidol toxicity? Case report and literature review. JPEN J Parenter Enteral Nutr. 1990;14:428– 430.

45.

Fell JM, Reynolds AP, Meadows N, et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet. 1996;347:1218– 1221.

46.

Taylor S, Manara AR. Manganese toxicity in a patient with cholestasis receiving total parenteral nutrition. Anaesthesia. 1994 ;49:1013 .

47.

Takagi Y, Okada A, Sando K, Wasa M, Yoshida H, Hirabuki N. On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level. JPEN J Parenter Enteral Nutr. 2001;25:87– 92.

48.

Fitzgerald K, Mikalunas V, Rubin H, McCarthy R, Vanagunas A, Craig RM. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1999 ;23:333– 336.

49.

Masumoto K, Suita S, Taguchi T, et al. Manganese intoxication during intermittent parenteral nutrition: report of two cases. JPEN J Parenter Enteral Nutr. 2001 ;25:95– 99.

50.

American Medical Association, Department of Foods and Nutrition. Guidelines for essential trace element preparations for parenteral use: a statement by an expert panel. JAMA. 1979 ;241:2051– 2054.

51.

Norose N, Araki K. Clinical studies on manganese deficiency during long-term parenteral nutrition in a child. Jpn J Parenter Enteral Nutr. 1987;9:978 .

52.

Kurkus J, Alcock NW, Shils ME. Manganese content of large volume parenteral solutions and of nutrient additives. JPEN J Parenter Enteral Nutr. 1994;8:254– 257.

53.

Dickerson RN. Manganese intoxication and parenteral nutrition. Nutrition. 2001;7:689– 693.

54.

Liu VJK, Morris JS. Relative chromium response as an indicator of chromium status. Am J Clin Nutr. 1978 ;31:972– 976.

55.

Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977 ;30:531– 538.

56.

Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. JAMA. 1979 ;241:496– 498.

57.

Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999 ;57:329– 335.

58.

Wongseelashote O, Daly MA, Frankel EH. High insulin requirement versus high chromium requirement in patients nourished with total parenteral nutrition. Nutrition. 2004 ;20:318– 320.

59.

Anderson RA. Chromium and parenteral nutrition. Nutrition. 1995 ;11(suppl):83– 86.

60.

DeBiasse-Fortin MA. Minerals and trace elements. In: Matarese LE, Gottschlich MM, eds. Contemporary Nutrition Support Practice: A Clinical Guide. 2^nd ed. Philadelphia, PA: Saunders;2003 : 164–172.

61.

Wolman SL, Anderson GH, Marliss EB, Jeejeebhoy KN. Zinc in total parenteral nutrition: requirements and metabolic effects. Gastroenterology. 1979 ;76:458– 467.

62.

Shrimpton R, Gross R, Darnton-Hill I, Young M. Zinc deficiency: what are the most appropriate interventions? BMJ. 2005 ;330:347– 349.

63.

Braunschweig CL, Sowers M, Kovacevich DS, Hill GM, August DA. Parenteral zinc supplementation in adult humans during the acute phase response increases the febrile response. J Nutr. 1997 ;127:70– 74.

64.

Howard L, Hassan N. Home parenteral nutrition 25 years later. Gastroenterol Clin North Am. 1998 ;27:481– 513.

65.

Billion-Rey F, Guillaumont M, Frederich A, Aulagner G. Stability of fat-soluble vitamin A (retinol palmitate), E (tocopherol acetate), and K (phylloquinone) in TPN at home. JPEN J Parenter Enteral Nutr. 1993;17:56– 60.

66.

Behrend C, Jeppesen PB, Mortensen PB. Vitamin B-12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery. Eur J Gastrol Hepatol. 1995 ;7:397– 400.

67.

Schoon EJ, Muller MCA, Vermeer C, Schurgers LJ, Brummer RJM, Stockbrugger RW. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor or osteoporosis in Crohn's disease? Gut. 2001 ;48:473– 477.

68.

Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Ped Gastroenterol Nutr. 1998 ;26:129– 135.

69.

Lavy A, Latcher J, Enat R, Kufman Y, Eidelman S. Deficiency of water-soluble vitamins in Crohn's disease. Dig Dis Sci. 1995;40:2549 .

70.

Hack SL, Merritt RJ, Morgan RM, Keefe MT. Serum vitamin A and E concentrations in pediatric total parenteral nutrition (TPN) patients. JPEN J Parenter Enteral Nutr. 1990 ;14:189– 194.

71.

A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002 ;26(suppl):1SA– 138SA. Errata 2002;26:144.

72.

NIH Office of the Director. NIH state-of-the-science panel urges more informed approach to multivitamin/mineral use for chronic disease prevention. http://www.nih.gov/news/pr/may2006/od-17.htm Accessed May 19, 2006.

73.

Boosalis MG. Vitamins. In: Matarese LE, Gottschlich MM, eds. Contemporary Nutrition Support Practice: A Clinical Guide. 2^nd ed. Philadelphia, PA: Saunders;2003 : 145–163.

74.

Parenteral multivitamin products: drugs for human use: drug efficacy study implementation: amendment (21 CFR 5.70). Fed Reg. 2000;65:21200– 21201.

75.

Chambrier C, Leclercq M, Saudin F, et al. Is vitamin K₁ supplementation necessary in long-term parenteral nutrition? JPEN J Parenter Enteral Nutr. 1998 ;22:87– 90.

76.

Helphingstine CJ, Bistrian BR. New food and drug administration requirements for inclusion of vitamin K in adult parenteral multivitamins. JPEN J Parenter Enteral Nutr. 2003 ;27:220– 224.

77.

Bern M. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy. JPEN J Parenter Enteral Nutr. 2004;28:388– 398.

78.

Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998 ;338:777– 783.

79.

Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ. 2002 ;166:1517– 1524.

80.

Moore CE, Murphy MM, Holick MF. Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr. 2005;135:2478– 2485.

81.

Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 ;28:289– 294.

82.

Verhage AH, Cheong WK, Allard JP, Jeejeebhoy KN. Increase in lumbar spine bone mineral content in patients on long-term parenteral nutrition without vitamin D supplementation. JPEN J Parenter Enteral Nutr. 1995;19:431– 436.

83.

Klein G. Metabolic bone disease of total parenteral nutrition. Nutrition. 1998 ;14:149– 152.

84.

Pen del Vega L, Lieske JC, Milliner D, Gonyea J, Kelly DG. Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enteral Nutr. 2004;28:435– 438.

85.

Romanski SA, McMahon MM. Metabolic acidosis and thiamine deficiency. Mayo Clin Proc. 1999 ;74:259– 263.

86.

Zak J III, Burns D, Lingenfelser T, Steyn E, Marks IN. Dry beriberi: unusual complication of prolonged parenteral nutrition. JPEN J Parenter Enteral Nutr. 1991 ;15:200– 201.

87.

Hahn JS, Berquist W, Alcorn DM, Chamberlain L, Bass D. Wernicke encephalopathy and beriberi during TPN attributable to multivitamin shortage. Pediatrics. 1998 ;101:E10 .

88.

Alloju M, Ehrinpreis MN. Shortage of intravenous multivitamin solution in the US. N Engl J Med. 1998 ;337:54– 55.

89.

Sauberlich HE. Laboratory Tests for the Assessment of Nutritional Status. 2^nd ed. Baton Rouge, LA: CRC Press; 1999.

90.

Mock DM, deLorimer AA, Liebman WM, Sweetman L, Baker H. Biotin deficiency: an unusual complication of parenteral alimentation. N Engl J Med. 1981 ;304:820– 823.

91.

Gillis J, Murphy FR, Boxall LBH, Pencharz PB. Biotin deficiency in a child on long-term TPN. JPEN J Parenter Enteral Nutr. 1982;6:308– 310.

92.

McClain CJ, Baker H, Onstad GR. Biotin deficiency in an adult during home parenteral nutrition. JAMA. 1982 ;247:3116– 3117.

93.

Davis A, Spillane R, Zublena L. Aluminum: a problem trace metal in nutrition support. Nutr Clin Pract. 1999 ;14:227– 231.

94.

Gura KM, Puder M. Recent developments in aluminum contamination of products used in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2006;9:239– 246.

95.

US Food and Drug Administration. Rules: TPN: aluminum in large and small volume parenterals: labeling requirements. Fed Reg. 2000;65:4103– 4111.

96.

ASCN/A.S.P.E.N. Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. Am J Clin Nutr. 1991 ;53:399– 402.

97.

Klein GL. Aluminum contamination of parenteral nutrition solutions and its impact on the pediatric patient. Nutr Clin Pract. 2003;18:302– 307.

98.

Speerhas R, Seidner DL. Actual aluminum content of parenteral nutrition is much less than calculated content. JPEN J Parenter Enteral Nutr. 2006;30:S22– S23.

99.

Misra S, Kirby DF. Micronutrient and trace element monitoring in adult nutrition support. Nutr Clin Pract. 2000 ;15:120– 126.

100.

Kelly DG. Guidelines and available products for parenteral vitamins and trace elements. JPEN J Parenter Enteral Nutr. 2002 ;26(suppl):S34– S36.